

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 9.93212837 |
| 2 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 9.93212837 |
| 3 | antigen processing and presentation of endogenous antigen (GO:0019883) | 8.80261729 |
| 4 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 5.70944646 |
| 5 | negative regulation of cell killing (GO:0031342) | 5.17323338 |
| 6 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.17323338 |
| 7 | positive regulation of interferon-alpha production (GO:0032727) | 5.17275176 |
| 8 | positive regulation of antigen processing and presentation (GO:0002579) | 5.09900234 |
| 9 | positive regulation by symbiont of host defense response (GO:0052509) | 5.09753820 |
| 10 | modulation by symbiont of host defense response (GO:0052031) | 5.09753820 |
| 11 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.09753820 |
| 12 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.09753820 |
| 13 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.09753820 |
| 14 | modulation by symbiont of host immune response (GO:0052553) | 5.09753820 |
| 15 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 5.08187052 |
| 16 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.05758317 |
| 17 | regulation of interferon-alpha production (GO:0032647) | 4.80939926 |
| 18 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.69348323 |
| 19 | cellular response to type I interferon (GO:0071357) | 4.65574331 |
| 20 | type I interferon signaling pathway (GO:0060337) | 4.65574331 |
| 21 | response to type I interferon (GO:0034340) | 4.60124460 |
| 22 | intracellular pH reduction (GO:0051452) | 4.55224335 |
| 23 | response to interferon-alpha (GO:0035455) | 4.29589419 |
| 24 | regulation of antigen processing and presentation (GO:0002577) | 4.26570713 |
| 25 | regulation of viral genome replication (GO:0045069) | 4.25304520 |
| 26 | * defense response to virus (GO:0051607) | 4.16306633 |
| 27 | low-density lipoprotein particle clearance (GO:0034383) | 4.16303417 |
| 28 | T cell migration (GO:0072678) | 4.15007930 |
| 29 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.96976746 |
| 30 | response to interferon-beta (GO:0035456) | 3.94924751 |
| 31 | positive regulation of type 2 immune response (GO:0002830) | 3.94794240 |
| 32 | negative regulation of T cell mediated immunity (GO:0002710) | 3.94232505 |
| 33 | cellular response to exogenous dsRNA (GO:0071360) | 3.91124961 |
| 34 | pH reduction (GO:0045851) | 3.90034262 |
| 35 | detection of other organism (GO:0098543) | 3.88606814 |
| 36 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.88244105 |
| 37 | detection of bacterium (GO:0016045) | 3.86917140 |
| 38 | negative regulation of viral process (GO:0048525) | 3.84672303 |
| 39 | macrophage activation involved in immune response (GO:0002281) | 3.82261300 |
| 40 | negative thymic T cell selection (GO:0045060) | 3.79868024 |
| 41 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.78617902 |
| 42 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.75609809 |
| 43 | regulation of MHC class I biosynthetic process (GO:0045343) | 3.75013181 |
| 44 | regulation of gamma-delta T cell activation (GO:0046643) | 3.74913812 |
| 45 | negative regulation of interleukin-12 production (GO:0032695) | 3.74773845 |
| 46 | respiratory burst (GO:0045730) | 3.73227332 |
| 47 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.72140159 |
| 48 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.67911320 |
| 49 | immunoglobulin mediated immune response (GO:0016064) | 3.67874517 |
| 50 | negative T cell selection (GO:0043383) | 3.64459401 |
| 51 | regulation of RIG-I signaling pathway (GO:0039535) | 3.64064492 |
| 52 | B cell receptor signaling pathway (GO:0050853) | 3.58873203 |
| 53 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.58064723 |
| 54 | response to interleukin-15 (GO:0070672) | 3.55010473 |
| 55 | regulation of cholesterol storage (GO:0010885) | 3.49934411 |
| 56 | cellular response to interleukin-15 (GO:0071350) | 3.48901897 |
| 57 | response to thyroid hormone (GO:0097066) | 3.48326629 |
| 58 | detection of external biotic stimulus (GO:0098581) | 3.44228050 |
| 59 | defense response to protozoan (GO:0042832) | 3.40144959 |
| 60 | negative regulation of viral genome replication (GO:0045071) | 3.38270024 |
| 61 | regulation of T cell tolerance induction (GO:0002664) | 3.36627460 |
| 62 | myeloid cell homeostasis (GO:0002262) | 3.36119608 |
| 63 | interferon-gamma production (GO:0032609) | 3.35189368 |
| 64 | regulation of interferon-beta production (GO:0032648) | 3.34553174 |
| 65 | positive regulation of defense response to virus by host (GO:0002230) | 3.33345549 |
| 66 | positive regulation of interferon-beta production (GO:0032728) | 3.32424583 |
| 67 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.31366524 |
| 68 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.31353565 |
| 69 | response to host immune response (GO:0052572) | 3.26561551 |
| 70 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.26561551 |
| 71 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.25091592 |
| 72 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.23686365 |
| 73 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.23446475 |
| 74 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.20275788 |
| 75 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.16858334 |
| 76 | cellular response to interferon-gamma (GO:0071346) | 3.16745189 |
| 77 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.16149941 |
| 78 | negative regulation of innate immune response (GO:0045824) | 3.15977165 |
| 79 | response to interferon-gamma (GO:0034341) | 3.15461412 |
| 80 | response to protozoan (GO:0001562) | 3.12495588 |
| 81 | positive thymic T cell selection (GO:0045059) | 3.11926086 |
| 82 | regulation of type 2 immune response (GO:0002828) | 3.08978676 |
| 83 | substrate-dependent cell migration (GO:0006929) | 3.08251922 |
| 84 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 3.07370314 |
| 85 | regulation of tolerance induction (GO:0002643) | 3.06128554 |
| 86 | negative regulation of type I interferon production (GO:0032480) | 3.04271852 |
| 87 | arginine catabolic process (GO:0006527) | 3.03346029 |
| 88 | phagosome maturation (GO:0090382) | 3.03063527 |
| 89 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 3.02115169 |
| 90 | negative regulation of B cell proliferation (GO:0030889) | 3.01369613 |
| 91 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.01196095 |
| 92 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.00119384 |
| 93 | detection of biotic stimulus (GO:0009595) | 2.96722278 |
| 94 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.94564256 |
| 95 | response to exogenous dsRNA (GO:0043330) | 2.94450060 |
| 96 | macrophage activation (GO:0042116) | 2.92753135 |
| 97 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.92473949 |
| 98 | regulation of B cell differentiation (GO:0045577) | 2.91857172 |
| 99 | plasma lipoprotein particle clearance (GO:0034381) | 2.91584955 |
| 100 | microglial cell activation (GO:0001774) | 2.91495342 |
| 101 | response to host (GO:0075136) | 2.90204790 |
| 102 | response to host defenses (GO:0052200) | 2.90204790 |
| 103 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.90204790 |
| 104 | germinal center formation (GO:0002467) | 2.89477047 |
| 105 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.89106009 |
| 106 | cellular response to virus (GO:0098586) | 2.88853805 |
| 107 | cellular response to interferon-beta (GO:0035458) | 2.88710473 |
| 108 | neutrophil activation involved in immune response (GO:0002283) | 2.87700865 |
| 109 | detection of molecule of bacterial origin (GO:0032490) | 2.87140929 |
| 110 | myeloid dendritic cell activation (GO:0001773) | 2.87013009 |
| 111 | cellular response to interferon-alpha (GO:0035457) | 2.83509781 |
| 112 | alpha-linolenic acid metabolic process (GO:0036109) | 2.83299291 |
| 113 | response to peptidoglycan (GO:0032494) | 2.79258074 |
| 114 | cell adhesion mediated by integrin (GO:0033627) | 2.73575750 |
| 115 | positive regulation of cytokine-mediated signaling pathway (GO:0001961) | 2.73345956 |
| 116 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.72513506 |
| 117 | aldehyde catabolic process (GO:0046185) | 2.70504462 |
| 118 | regulation of mononuclear cell migration (GO:0071675) | 2.69572100 |
| 119 | regulation of protein heterodimerization activity (GO:0043497) | 2.67856296 |
| 120 | myeloid dendritic cell differentiation (GO:0043011) | 2.67635444 |
| 121 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.67317134 |
| 122 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.65040730 |
| 123 | regulation of toll-like receptor signaling pathway (GO:0034121) | 2.64142361 |
| 124 | regulation of intracellular pH (GO:0051453) | 2.62323392 |
| 125 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.62319250 |
| 126 | B cell mediated immunity (GO:0019724) | 2.62098830 |
| 127 | nitric oxide biosynthetic process (GO:0006809) | 2.60448011 |
| 128 | sequestering of metal ion (GO:0051238) | 2.59591060 |
| 129 | cytidine deamination (GO:0009972) | 2.57679505 |
| 130 | cytidine metabolic process (GO:0046087) | 2.57679505 |
| 131 | cytidine catabolic process (GO:0006216) | 2.57679505 |
| 132 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.53070979 |
| 133 | T-helper 1 type immune response (GO:0042088) | 2.52971096 |
| 134 | positive regulation of response to cytokine stimulus (GO:0060760) | 2.51684030 |
| 135 | negative regulation of interleukin-17 production (GO:0032700) | 2.50862495 |
| 136 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.50849712 |
| 137 | basic amino acid transport (GO:0015802) | 2.47133675 |
| 138 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.46580433 |
| 139 | negative regulation of mast cell activation (GO:0033004) | 2.45454155 |
| 140 | lymphocyte chemotaxis (GO:0048247) | 2.45359844 |
| 141 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.44520876 |
| 142 | response to muramyl dipeptide (GO:0032495) | 2.44295856 |
| 143 | positive regulation of guanylate cyclase activity (GO:0031284) | 2.44182040 |
| 144 | protein localization to endosome (GO:0036010) | 2.43780558 |
| 145 | positive regulation of B cell differentiation (GO:0045579) | 2.42972582 |
| 146 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.42299172 |
| 147 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.42274939 |
| 148 | regulation of cellular pH (GO:0030641) | 2.40425392 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.69015040 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 6.65260148 |
| 3 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 6.03916247 |
| 4 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.17898608 |
| 5 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.57045984 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.55911897 |
| 7 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 3.51210467 |
| 8 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.36038382 |
| 9 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.26570392 |
| 10 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.10456960 |
| 11 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.85055406 |
| 12 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.84459791 |
| 13 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.66478713 |
| 14 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.50783035 |
| 15 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.42974028 |
| 16 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.42739621 |
| 17 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.32981496 |
| 18 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.28383893 |
| 19 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.28326206 |
| 20 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.23652857 |
| 21 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.19800207 |
| 22 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.09850530 |
| 23 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.01845495 |
| 24 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.01447003 |
| 25 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.99510706 |
| 26 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.87423734 |
| 27 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.79264456 |
| 28 | GATA1_22025678_ChIP-Seq_K562_Human | 1.69069617 |
| 29 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.66687152 |
| 30 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.66341326 |
| 31 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.65754876 |
| 32 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.65335318 |
| 33 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.63468851 |
| 34 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.60717615 |
| 35 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.59650455 |
| 36 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.56708172 |
| 37 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.55852360 |
| 38 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.54939919 |
| 39 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.50542764 |
| 40 | SPI1_23127762_ChIP-Seq_K562_Human | 1.50229933 |
| 41 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.50129634 |
| 42 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.49260321 |
| 43 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.47501000 |
| 44 | MAF_26560356_Chip-Seq_TH1_Human | 1.47043237 |
| 45 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.44416799 |
| 46 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.42408517 |
| 47 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.39034038 |
| 48 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.38973302 |
| 49 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.38036250 |
| 50 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.36473094 |
| 51 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.34451123 |
| 52 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.32906269 |
| 53 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.31991026 |
| 54 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.30676502 |
| 55 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.29301857 |
| 56 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.27207652 |
| 57 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.26335709 |
| 58 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.24560318 |
| 59 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.23537276 |
| 60 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.23271785 |
| 61 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.23069523 |
| 62 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.22442293 |
| 63 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.22376058 |
| 64 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.18335907 |
| 65 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.17467505 |
| 66 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.16447489 |
| 67 | MYB_26560356_Chip-Seq_TH2_Human | 1.15879286 |
| 68 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.15707027 |
| 69 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.14191996 |
| 70 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.13404520 |
| 71 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.11271682 |
| 72 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.08986445 |
| 73 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.08002869 |
| 74 | UTX_26944678_Chip-Seq_JUKART_Human | 1.07565229 |
| 75 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.06363334 |
| 76 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.04927507 |
| 77 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.03939289 |
| 78 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.03797099 |
| 79 | SMRT_27268052_Chip-Seq_Bcells_Human | 1.03306710 |
| 80 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.01991848 |
| 81 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.01272595 |
| 82 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.00257834 |
| 83 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.99927263 |
| 84 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 0.98422382 |
| 85 | GATA1_19941826_ChIP-Seq_K562_Human | 0.96262564 |
| 86 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.95805860 |
| 87 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.95361723 |
| 88 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.94836415 |
| 89 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.93296285 |
| 90 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.93132688 |
| 91 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.91857102 |
| 92 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.90825355 |
| 93 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.90664730 |
| 94 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.90176491 |
| 95 | MYB_26560356_Chip-Seq_TH1_Human | 0.89941303 |
| 96 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.89668469 |
| 97 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.89636153 |
| 98 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.89053938 |
| 99 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.89051928 |
| 100 | MAF_26560356_Chip-Seq_TH2_Human | 0.89036992 |
| 101 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.88873462 |
| 102 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.88457590 |
| 103 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.88457590 |
| 104 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.87535271 |
| 105 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.87213887 |
| 106 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.86950413 |
| 107 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.86806042 |
| 108 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.86536600 |
| 109 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.85267693 |
| 110 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.85036848 |
| 111 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.83400589 |
| 112 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.83060747 |
| 113 | MYC_22102868_ChIP-Seq_BL_Human | 0.82997488 |
| 114 | GATA3_26560356_Chip-Seq_TH2_Human | 0.82305166 |
| 115 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.81044909 |
| 116 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.79465013 |
| 117 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.79171874 |
| 118 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.78626509 |
| 119 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.77954733 |
| 120 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.77279832 |
| 121 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.76904217 |
| 122 | GATA3_26560356_Chip-Seq_TH1_Human | 0.76717897 |
| 123 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.76523892 |
| 124 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.73123210 |
| 125 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.73095138 |
| 126 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.72968938 |
| 127 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.68959015 |
| 128 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.68500291 |
| 129 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.66698487 |
| 130 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.64946310 |
| 131 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.62139722 |
| 132 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.58264745 |
| 133 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.57581876 |
| 134 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.55776562 |
| 135 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.54271656 |
| 136 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.54176301 |
| 137 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.52976298 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005058_abnormal_lysosome_morphology | 4.26757272 |
| 2 | MP0001835_abnormal_antigen_presentation | 3.53313887 |
| 3 | MP0000604_amyloidosis | 3.38182432 |
| 4 | MP0003303_peritoneal_inflammation | 3.33475172 |
| 5 | MP0004510_myositis | 3.20479044 |
| 6 | MP0006082_CNS_inflammation | 3.13851440 |
| 7 | MP0003191_abnormal_cellular_cholesterol | 3.03859264 |
| 8 | MP0003436_decreased_susceptibility_to | 2.84982390 |
| 9 | MP0003172_abnormal_lysosome_physiology | 2.73742030 |
| 10 | MP0003763_abnormal_thymus_physiology | 2.68596882 |
| 11 | MP0008438_abnormal_cutaneous_collagen | 2.60037528 |
| 12 | MP0004858_abnormal_nervous_system | 2.49728797 |
| 13 | MP0009785_altered_susceptibility_to | 2.46599764 |
| 14 | MP0003300_gastrointestinal_ulcer | 2.36351080 |
| 15 | MP0009840_abnormal_foam_cell | 2.35981605 |
| 16 | MP0002419_abnormal_innate_immunity | 2.25948397 |
| 17 | MP0001533_abnormal_skeleton_physiology | 2.17363386 |
| 18 | MP0005025_abnormal_response_to | 2.14557178 |
| 19 | MP0003724_increased_susceptibility_to | 2.09516344 |
| 20 | MP0001790_abnormal_immune_system | 2.08486141 |
| 21 | MP0005387_immune_system_phenotype | 2.08486141 |
| 22 | MP0005360_urolithiasis | 2.00535992 |
| 23 | MP0010307_abnormal_tumor_latency | 1.99513989 |
| 24 | MP0003448_altered_tumor_morphology | 1.98993869 |
| 25 | MP0000343_altered_response_to | 1.95847631 |
| 26 | MP0000685_abnormal_immune_system | 1.95512463 |
| 27 | MP0005000_abnormal_immune_tolerance | 1.91912724 |
| 28 | MP0003329_amyloid_beta_deposits | 1.90577078 |
| 29 | MP0003690_abnormal_glial_cell | 1.82615073 |
| 30 | MP0005464_abnormal_platelet_physiology | 1.73789103 |
| 31 | MP0004947_skin_inflammation | 1.73714713 |
| 32 | MP0003075_altered_response_to | 1.72569657 |
| 33 | MP0002452_abnormal_antigen_presenting | 1.66026283 |
| 34 | MP0002166_altered_tumor_susceptibility | 1.64667733 |
| 35 | MP0002139_abnormal_hepatobiliary_system | 1.64438239 |
| 36 | MP0002138_abnormal_hepatobiliary_system | 1.61263695 |
| 37 | MP0002722_abnormal_immune_system | 1.58075159 |
| 38 | MP0005167_abnormal_blood-brain_barrier | 1.57452030 |
| 39 | MP0001958_emphysema | 1.55810179 |
| 40 | MP0005310_abnormal_salivary_gland | 1.53310062 |
| 41 | MP0008469_abnormal_protein_level | 1.51697875 |
| 42 | MP0001845_abnormal_inflammatory_respons | 1.49386850 |
| 43 | MP0001853_heart_inflammation | 1.48792095 |
| 44 | MP0001800_abnormal_humoral_immune | 1.48260910 |
| 45 | MP0002723_abnormal_immune_serum | 1.47945777 |
| 46 | MP0005257_abnormal_intraocular_pressure | 1.47316049 |
| 47 | MP0000703_abnormal_thymus_morphology | 1.45584764 |
| 48 | MP0003183_abnormal_peptide_metabolism | 1.42851887 |
| 49 | MP0001851_eye_inflammation | 1.39595276 |
| 50 | MP0003045_fibrosis | 1.38494946 |
| 51 | MP0003705_abnormal_hypodermis_morpholog | 1.36723749 |
| 52 | MP0001819_abnormal_immune_cell | 1.34721951 |
| 53 | MP0003656_abnormal_erythrocyte_physiolo | 1.34608811 |
| 54 | MP0005166_decreased_susceptibility_to | 1.34082838 |
| 55 | MP0002148_abnormal_hypersensitivity_rea | 1.33183517 |
| 56 | MP0002998_abnormal_bone_remodeling | 1.32174237 |
| 57 | MP0002420_abnormal_adaptive_immunity | 1.30872150 |
| 58 | MP0003866_abnormal_defecation | 1.30372982 |
| 59 | MP0002396_abnormal_hematopoietic_system | 1.30348419 |
| 60 | MP0003566_abnormal_cell_adhesion | 1.26762120 |
| 61 | MP0008875_abnormal_xenobiotic_pharmacok | 1.25962126 |
| 62 | MP0005164_abnormal_response_to | 1.24111876 |
| 63 | MP0001873_stomach_inflammation | 1.20556306 |
| 64 | MP0005671_abnormal_response_to | 1.20162987 |
| 65 | MP0005365_abnormal_bile_salt | 1.18793122 |
| 66 | MP0005451_abnormal_body_composition | 1.16725421 |
| 67 | MP0005083_abnormal_biliary_tract | 1.15615655 |
| 68 | MP0002933_joint_inflammation | 1.14288539 |
| 69 | MP0004808_abnormal_hematopoietic_stem | 1.14085832 |
| 70 | MP0001348_abnormal_lacrimal_gland | 1.12479118 |
| 71 | MP0006054_spinal_hemorrhage | 1.12363919 |
| 72 | MP0000569_abnormal_digit_pigmentation | 1.09604944 |
| 73 | MP0010234_abnormal_vibrissa_follicle | 1.09413143 |
| 74 | MP0004782_abnormal_surfactant_physiolog | 1.08849745 |
| 75 | MP0009764_decreased_sensitivity_to | 1.08373265 |
| 76 | MP0002405_respiratory_system_inflammati | 1.07205100 |
| 77 | MP0010329_abnormal_lipoprotein_level | 1.05252224 |
| 78 | MP0005319_abnormal_enzyme/_coenzyme | 1.05047312 |
| 79 | MP0010155_abnormal_intestine_physiology | 1.03800476 |
| 80 | MP0000858_altered_metastatic_potential | 1.03290198 |
| 81 | MP0000249_abnormal_blood_vessel | 1.02900316 |
| 82 | MP0002254_reproductive_system_inflammat | 1.01993509 |
| 83 | MP0003186_abnormal_redox_activity | 1.01544085 |
| 84 | MP0000465_gastrointestinal_hemorrhage | 1.00184169 |
| 85 | MP0000609_abnormal_liver_physiology | 1.00126897 |
| 86 | MP0009333_abnormal_splenocyte_physiolog | 0.99406694 |
| 87 | MP0002006_tumorigenesis | 0.93827052 |
| 88 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.92263134 |
| 89 | MP0000716_abnormal_immune_system | 0.92255401 |
| 90 | MP0005023_abnormal_wound_healing | 0.90077726 |
| 91 | MP0004019_abnormal_vitamin_homeostasis | 0.89908577 |
| 92 | MP0004381_abnormal_hair_follicle | 0.88646296 |
| 93 | MP0005390_skeleton_phenotype | 0.88207252 |
| 94 | MP0004130_abnormal_muscle_cell | 0.87928703 |
| 95 | MP0005397_hematopoietic_system_phenotyp | 0.87062360 |
| 96 | MP0001545_abnormal_hematopoietic_system | 0.87062360 |
| 97 | MP0009763_increased_sensitivity_to | 0.86807944 |
| 98 | MP0002136_abnormal_kidney_physiology | 0.84802314 |
| 99 | MP0000689_abnormal_spleen_morphology | 0.84533830 |
| 100 | MP0001879_abnormal_lymphatic_vessel | 0.83476637 |
| 101 | MP0009643_abnormal_urine_homeostasis | 0.82528996 |
| 102 | MP0005085_abnormal_gallbladder_physiolo | 0.82038588 |
| 103 | MP0004883_abnormal_blood_vessel | 0.81783732 |
| 104 | MP0003091_abnormal_cell_migration | 0.81107952 |
| 105 | MP0002163_abnormal_gland_morphology | 0.80545166 |
| 106 | MP0001756_abnormal_urination | 0.80208525 |
| 107 | MP0008260_abnormal_autophagy | 0.79981225 |
| 108 | MP0002332_abnormal_exercise_endurance | 0.79074833 |
| 109 | MP0009278_abnormal_bone_marrow | 0.78695180 |
| 110 | MP0000598_abnormal_liver_morphology | 0.78572521 |
| 111 | MP0003828_pulmonary_edema | 0.78074602 |
| 112 | MP0005197_abnormal_uvea_morphology | 0.77724442 |
| 113 | MP0002090_abnormal_vision | 0.77511621 |
| 114 | MP0002277_abnormal_respiratory_mucosa | 0.76842159 |
| 115 | MP0005332_abnormal_amino_acid | 0.75992945 |
| 116 | MP0002429_abnormal_blood_cell | 0.75010313 |
| 117 | MP0001881_abnormal_mammary_gland | 0.74536087 |
| 118 | MP0002398_abnormal_bone_marrow | 0.74494932 |
| 119 | MP0003221_abnormal_cardiomyocyte_apopto | 0.74109755 |
| 120 | MP0002118_abnormal_lipid_homeostasis | 0.72536902 |
| 121 | MP0005075_abnormal_melanosome_morpholog | 0.69293837 |
| 122 | MP0002019_abnormal_tumor_incidence | 0.65316512 |
| 123 | MP0002132_abnormal_respiratory_system | 0.65196732 |
| 124 | MP0009765_abnormal_xenobiotic_induced | 0.63615784 |
| 125 | MP0009115_abnormal_fat_cell | 0.63131028 |
| 126 | MP0008057_abnormal_DNA_replication | 0.61640752 |
| 127 | MP0003795_abnormal_bone_structure | 0.59011390 |
| 128 | MP0008874_decreased_physiological_sensi | 0.56854635 |
| 129 | MP0002693_abnormal_pancreas_physiology | 0.56519368 |
| 130 | MP0002168_other_aberrant_phenotype | 0.56512838 |
| 131 | MP0001663_abnormal_digestive_system | 0.55825700 |
| 132 | MP0003806_abnormal_nucleotide_metabolis | 0.54544195 |
| 133 | MP0000920_abnormal_myelination | 0.48305895 |
| 134 | MP0000371_diluted_coat_color | 0.43247645 |
| 135 | MP0005379_endocrine/exocrine_gland_phen | 0.42941085 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Chronic otitis media (HP:0000389) | 6.15942248 |
| 2 | Increased cerebral lipofuscin (HP:0011813) | 5.84125134 |
| 3 | Chronic mucocutaneous candidiasis (HP:0002728) | 5.31288266 |
| 4 | Recurrent cutaneous fungal infections (HP:0011370) | 5.31288266 |
| 5 | Optic neuritis (HP:0100653) | 5.20559758 |
| 6 | Retrobulbar optic neuritis (HP:0100654) | 5.20559758 |
| 7 | Vacuolated lymphocytes (HP:0001922) | 5.15173824 |
| 8 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 5.08270416 |
| 9 | Recurrent fungal infections (HP:0002841) | 4.73515991 |
| 10 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 4.55056857 |
| 11 | Vasculitis (HP:0002633) | 4.52215622 |
| 12 | Abnormality of macrophages (HP:0004311) | 4.42830084 |
| 13 | Gastrointestinal infarctions (HP:0005244) | 4.39846522 |
| 14 | Nasal polyposis (HP:0100582) | 4.39290713 |
| 15 | Meningitis (HP:0001287) | 4.38960780 |
| 16 | Recurrent abscess formation (HP:0002722) | 4.35796324 |
| 17 | Abnormality of the nasal mucosa (HP:0000433) | 4.26091762 |
| 18 | Autoimmune hemolytic anemia (HP:0001890) | 4.20338491 |
| 19 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.19675570 |
| 20 | Dysostosis multiplex (HP:0000943) | 4.18372284 |
| 21 | Panhypogammaglobulinemia (HP:0003139) | 4.12303525 |
| 22 | Abnormality of T cell number (HP:0011839) | 4.01134363 |
| 23 | Pulmonary infiltrates (HP:0002113) | 3.92957421 |
| 24 | Axonal loss (HP:0003447) | 3.88526811 |
| 25 | Agammaglobulinemia (HP:0004432) | 3.83976371 |
| 26 | Eczematoid dermatitis (HP:0000976) | 3.83322550 |
| 27 | T lymphocytopenia (HP:0005403) | 3.79486932 |
| 28 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.78896973 |
| 29 | Mucopolysacchariduria (HP:0008155) | 3.78896973 |
| 30 | Loss of speech (HP:0002371) | 3.77785670 |
| 31 | Systemic lupus erythematosus (HP:0002725) | 3.77024812 |
| 32 | Hemoptysis (HP:0002105) | 3.73560329 |
| 33 | Encephalitis (HP:0002383) | 3.72104215 |
| 34 | Disinhibition (HP:0000734) | 3.67090090 |
| 35 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.66584996 |
| 36 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.66584996 |
| 37 | Abnormality of glycolipid metabolism (HP:0010969) | 3.66584996 |
| 38 | Recurrent bacterial skin infections (HP:0005406) | 3.57173942 |
| 39 | Stomatitis (HP:0010280) | 3.57163134 |
| 40 | Keratoconjunctivitis sicca (HP:0001097) | 3.53660128 |
| 41 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.46315263 |
| 42 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.46315263 |
| 43 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.46315263 |
| 44 | Keratoconjunctivitis (HP:0001096) | 3.41864357 |
| 45 | IgG deficiency (HP:0004315) | 3.41581168 |
| 46 | Abnormality of T cells (HP:0002843) | 3.41294527 |
| 47 | Colitis (HP:0002583) | 3.33153960 |
| 48 | Gastrointestinal stroma tumor (HP:0100723) | 3.32069095 |
| 49 | Increased IgM level (HP:0003496) | 3.26443270 |
| 50 | Myocardial infarction (HP:0001658) | 3.26312883 |
| 51 | Abnormality of T cell physiology (HP:0011840) | 3.21901461 |
| 52 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 3.16599256 |
| 53 | Conjunctival telangiectasia (HP:0000524) | 3.12953535 |
| 54 | Arterial thrombosis (HP:0004420) | 3.07071726 |
| 55 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.05043139 |
| 56 | Chest pain (HP:0100749) | 3.03044052 |
| 57 | Chronic sinusitis (HP:0011109) | 3.02421474 |
| 58 | Recurrent bronchitis (HP:0002837) | 3.01175254 |
| 59 | IgA deficiency (HP:0002720) | 3.00177720 |
| 60 | Recurrent sinusitis (HP:0011108) | 2.98449290 |
| 61 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.95708888 |
| 62 | Inflammation of the large intestine (HP:0002037) | 2.94012656 |
| 63 | Abnormality of B cell number (HP:0010975) | 2.91721435 |
| 64 | Autoimmune thrombocytopenia (HP:0001973) | 2.90585030 |
| 65 | Lymphopenia (HP:0001888) | 2.90209341 |
| 66 | Global brain atrophy (HP:0002283) | 2.88630704 |
| 67 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.87273267 |
| 68 | Neurofibrillary tangles (HP:0002185) | 2.86586274 |
| 69 | Tetraparesis (HP:0002273) | 2.86181310 |
| 70 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.78759167 |
| 71 | Hypergammaglobulinemia (HP:0010702) | 2.78125440 |
| 72 | Hepatosplenomegaly (HP:0001433) | 2.76023582 |
| 73 | Gastrointestinal inflammation (HP:0004386) | 2.75675757 |
| 74 | Leukocytosis (HP:0001974) | 2.75362976 |
| 75 | IgM deficiency (HP:0002850) | 2.71061522 |
| 76 | Pulmonary embolism (HP:0002204) | 2.69808318 |
| 77 | Eosinophilia (HP:0001880) | 2.69210545 |
| 78 | Myositis (HP:0100614) | 2.69002834 |
| 79 | Abnormality of the pleura (HP:0002103) | 2.68534245 |
| 80 | Gangrene (HP:0100758) | 2.64674834 |
| 81 | Complement deficiency (HP:0004431) | 2.64411176 |
| 82 | Diminished motivation (HP:0000745) | 2.61415305 |
| 83 | Chronic obstructive pulmonary disease (HP:0006510) | 2.58514465 |
| 84 | Obstructive lung disease (HP:0006536) | 2.58514465 |
| 85 | Increased IgE level (HP:0003212) | 2.57716280 |
| 86 | Granulocytopenia (HP:0001913) | 2.57187528 |
| 87 | Abnormality of the prostate (HP:0008775) | 2.56417573 |
| 88 | Basal ganglia calcification (HP:0002135) | 2.54844693 |
| 89 | Apathy (HP:0000741) | 2.49906460 |
| 90 | Anorexia (HP:0002039) | 2.49863712 |
| 91 | Gingivitis (HP:0000230) | 2.48949537 |
| 92 | Joint hemorrhage (HP:0005261) | 2.47739899 |
| 93 | Hypercholesterolemia (HP:0003124) | 2.46781325 |
| 94 | Cerebral inclusion bodies (HP:0100314) | 2.46153643 |
| 95 | Xanthomatosis (HP:0000991) | 2.46143068 |
| 96 | Mucosal telangiectasiae (HP:0100579) | 2.45215971 |
| 97 | Hypochromic anemia (HP:0001931) | 2.44719825 |
| 98 | B lymphocytopenia (HP:0010976) | 2.44269970 |
| 99 | Supranuclear gaze palsy (HP:0000605) | 2.43066941 |
| 100 | Spastic diplegia (HP:0001264) | 2.42302029 |
| 101 | Viral hepatitis (HP:0006562) | 2.42290782 |
| 102 | Emphysema (HP:0002097) | 2.42040309 |
| 103 | Asymmetric septal hypertrophy (HP:0001670) | 2.40627375 |
| 104 | Chronic diarrhea (HP:0002028) | 2.40495886 |
| 105 | Hematochezia (HP:0002573) | 2.39978199 |
| 106 | Cerebral aneurysm (HP:0004944) | 2.38602496 |
| 107 | Spontaneous hematomas (HP:0007420) | 2.38496899 |
| 108 | Glomerulonephritis (HP:0000099) | 2.37950481 |
| 109 | Orchitis (HP:0100796) | 2.37610748 |
| 110 | Abnormality of the endocardium (HP:0004306) | 2.35787538 |
| 111 | Restrictive lung disease (HP:0002091) | 2.35530052 |
| 112 | Striae distensae (HP:0001065) | 2.34353014 |
| 113 | Hypochromic microcytic anemia (HP:0004840) | 2.33174022 |
| 114 | Increased serum ferritin (HP:0003281) | 2.32325429 |
| 115 | Spondylolisthesis (HP:0003302) | 2.31293596 |
| 116 | Interstitial pulmonary disease (HP:0006530) | 2.31099841 |
| 117 | Recurrent skin infections (HP:0001581) | 2.30148307 |
| 118 | Abnormality of eosinophils (HP:0001879) | 2.29203812 |
| 119 | Abnormality of the peritoneum (HP:0002585) | 2.28340446 |
| 120 | Mediastinal lymphadenopathy (HP:0100721) | 2.26952498 |
| 121 | Porencephaly (HP:0002132) | 2.25765847 |
| 122 | Stomach cancer (HP:0012126) | 2.24284484 |
| 123 | Pustule (HP:0200039) | 2.23529842 |
| 124 | Abnormality of complement system (HP:0005339) | 2.22947572 |
| 125 | Esophageal varix (HP:0002040) | 2.21875801 |
| 126 | Recurrent pneumonia (HP:0006532) | 2.21055863 |
| 127 | Gingival bleeding (HP:0000225) | 2.20012519 |
| 128 | Urticaria (HP:0001025) | 2.19636760 |
| 129 | Bronchitis (HP:0012387) | 2.17572069 |
| 130 | Recurrent lower respiratory tract infections (HP:0002783) | 2.15842680 |
| 131 | Deep venous thrombosis (HP:0002625) | 2.14634133 |
| 132 | Polyneuropathy (HP:0001271) | 2.14491346 |
| 133 | Abnormality of the pericardium (HP:0001697) | 2.13105819 |
| 134 | Neuronal loss in central nervous system (HP:0002529) | 2.12669507 |
| 135 | Cheilitis (HP:0100825) | 2.11434293 |
| 136 | Lymphoma (HP:0002665) | 2.09218354 |
| 137 | Pathologic fracture (HP:0002756) | 2.08385418 |
| 138 | Protuberant abdomen (HP:0001538) | 2.08348018 |
| 139 | Papilledema (HP:0001085) | 2.07720503 |
| 140 | Keratitis (HP:0000491) | 2.06681093 |
| 141 | Abnormality of iron homeostasis (HP:0011031) | 2.06679993 |
| 142 | Upper motor neuron abnormality (HP:0002127) | 2.05385874 |
| 143 | Sepsis (HP:0100806) | 2.04167100 |
| 144 | J-shaped sella turcica (HP:0002680) | 2.03905891 |
| 145 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.02816141 |
| 146 | Osteolytic defects of the hand bones (HP:0009699) | 2.02816141 |
| 147 | Vertebral compression fractures (HP:0002953) | 2.02784341 |
| 148 | Cellulitis (HP:0100658) | 2.01781158 |
| 149 | Hyperlipoproteinemia (HP:0010980) | 2.01503159 |
| 150 | Skin ulcer (HP:0200042) | 2.00845664 |
| 151 | Hydroxyprolinuria (HP:0003080) | 2.00278638 |
| 152 | Abnormality of proline metabolism (HP:0010907) | 2.00278638 |
| 153 | Premature loss of primary teeth (HP:0006323) | 2.00182672 |
| 154 | Skin rash (HP:0000988) | 2.00095032 |
| 155 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.99226031 |
| 156 | Increased CSF protein (HP:0002922) | 1.98975925 |
| 157 | Amaurosis fugax (HP:0100576) | 1.98345433 |
| 158 | Peripheral demyelination (HP:0011096) | 1.98003899 |
| 159 | Arthralgia (HP:0002829) | 1.97947329 |
| 160 | Nephritis (HP:0000123) | 1.96179967 |
| 161 | Bone pain (HP:0002653) | 1.95135874 |
| 162 | Premature rupture of membranes (HP:0001788) | 1.95054384 |
| 163 | Ectopia lentis (HP:0001083) | 1.93041766 |
| 164 | Recurrent viral infections (HP:0004429) | 1.89552154 |
| 165 | Progressive neurologic deterioration (HP:0002344) | 1.89244308 |
| 166 | Peritonitis (HP:0002586) | 1.87737364 |
| 167 | Abnormal platelet function (HP:0011869) | 1.87161364 |
| 168 | Impaired platelet aggregation (HP:0003540) | 1.87161364 |
| 169 | Inappropriate behavior (HP:0000719) | 1.86265084 |
| 170 | Amyloidosis (HP:0011034) | 1.85970604 |
| 171 | Osteomyelitis (HP:0002754) | 1.85454832 |
| 172 | Agnosia (HP:0010524) | 1.83816464 |
| 173 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.78547801 |
| 174 | Aortic dissection (HP:0002647) | 1.77399694 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | KIT | 4.72180680 |
| 2 | TBK1 | 4.13760286 |
| 3 | ERN1 | 3.87714689 |
| 4 | NME2 | 3.46080560 |
| 5 | TYK2 | 3.31956337 |
| 6 | TRIB3 | 2.81721234 |
| 7 | TXK | 2.79010498 |
| 8 | IKBKE | 2.73180503 |
| 9 | TGFBR2 | 2.69917244 |
| 10 | FGFR4 | 2.62597986 |
| 11 | EPHB1 | 2.08295026 |
| 12 | IRAK3 | 2.07900743 |
| 13 | BMX | 2.06049969 |
| 14 | PKN2 | 1.95647283 |
| 15 | KDR | 1.88412503 |
| 16 | FGR | 1.87776765 |
| 17 | BLK | 1.87434257 |
| 18 | FRK | 1.86059702 |
| 19 | PTK6 | 1.81433835 |
| 20 | JAK1 | 1.79365466 |
| 21 | BMPR2 | 1.75502388 |
| 22 | FES | 1.71893915 |
| 23 | PRPF4B | 1.66724920 |
| 24 | CSK | 1.66378880 |
| 25 | TNK2 | 1.65781329 |
| 26 | CSF1R | 1.64538156 |
| 27 | TTN | 1.63199729 |
| 28 | FGFR3 | 1.54240525 |
| 29 | JAK3 | 1.49797770 |
| 30 | ITK | 1.48693292 |
| 31 | TEC | 1.47188943 |
| 32 | LRRK2 | 1.37333896 |
| 33 | RPS6KA4 | 1.33837572 |
| 34 | MAP3K9 | 1.30377350 |
| 35 | KSR2 | 1.25446192 |
| 36 | PBK | 1.24161167 |
| 37 | MAP3K14 | 1.23716603 |
| 38 | IRAK4 | 1.21376887 |
| 39 | SCYL2 | 1.21009288 |
| 40 | TESK1 | 1.19625411 |
| 41 | IRAK1 | 1.16612981 |
| 42 | MOS | 1.14607961 |
| 43 | PAK4 | 1.13998248 |
| 44 | RIPK1 | 1.12816003 |
| 45 | ABL2 | 1.10784376 |
| 46 | MAP3K13 | 1.08799808 |
| 47 | MATK | 1.07153760 |
| 48 | MAP2K3 | 1.06142181 |
| 49 | CAMKK2 | 1.05784230 |
| 50 | MAP4K1 | 1.05032005 |
| 51 | GRK7 | 1.04311452 |
| 52 | ARAF | 1.02604407 |
| 53 | GRK6 | 0.95537886 |
| 54 | JAK2 | 0.95115414 |
| 55 | SYK | 0.94179526 |
| 56 | NEK9 | 0.93905546 |
| 57 | HCK | 0.93452065 |
| 58 | MAP3K3 | 0.93000697 |
| 59 | CAMK1D | 0.91728580 |
| 60 | EGFR | 0.90817624 |
| 61 | CAMKK1 | 0.89036382 |
| 62 | TESK2 | 0.84406744 |
| 63 | MARK3 | 0.83774122 |
| 64 | TAOK3 | 0.83548316 |
| 65 | CDC42BPA | 0.83065210 |
| 66 | NLK | 0.82565772 |
| 67 | PRKCQ | 0.80198649 |
| 68 | IKBKB | 0.78623436 |
| 69 | RET | 0.76952735 |
| 70 | EIF2AK2 | 0.74017197 |
| 71 | ALK | 0.73133228 |
| 72 | TGFBR1 | 0.72274973 |
| 73 | MAP3K1 | 0.71542606 |
| 74 | MAPK7 | 0.71038059 |
| 75 | LCK | 0.67757164 |
| 76 | ZAP70 | 0.67389389 |
| 77 | CHUK | 0.65864848 |
| 78 | BCKDK | 0.65546206 |
| 79 | PRKCH | 0.64748596 |
| 80 | LYN | 0.64385015 |
| 81 | ACVR1B | 0.62169974 |
| 82 | HIPK2 | 0.62107701 |
| 83 | RIPK4 | 0.60864087 |
| 84 | MAP3K11 | 0.60480600 |
| 85 | PRKG2 | 0.58968026 |
| 86 | PIM2 | 0.58171576 |
| 87 | ADRBK2 | 0.58078865 |
| 88 | PIM1 | 0.57955793 |
| 89 | CAMK1G | 0.56291853 |
| 90 | ABL1 | 0.55954655 |
| 91 | MELK | 0.55318910 |
| 92 | YES1 | 0.55232179 |
| 93 | SIK2 | 0.54968187 |
| 94 | LIMK1 | 0.54573190 |
| 95 | PAK6 | 0.54355544 |
| 96 | DDR2 | 0.54087154 |
| 97 | SIK3 | 0.53134470 |
| 98 | MAP3K6 | 0.51957113 |
| 99 | MAP3K2 | 0.51109608 |
| 100 | PDGFRA | 0.50112784 |
| 101 | PRKCD | 0.49757632 |
| 102 | BTK | 0.49376864 |
| 103 | CDK6 | 0.48961497 |
| 104 | FYN | 0.47423129 |
| 105 | ILK | 0.47095642 |
| 106 | STK10 | 0.46365928 |
| 107 | SGK2 | 0.45664790 |
| 108 | SRC | 0.45528106 |
| 109 | PDPK1 | 0.45394971 |
| 110 | STK24 | 0.45346311 |
| 111 | PTK2B | 0.45151299 |
| 112 | SGK3 | 0.44417215 |
| 113 | MAP3K5 | 0.44018284 |
| 114 | EPHA3 | 0.43413246 |
| 115 | GSK3A | 0.42254945 |
| 116 | EIF2AK3 | 0.42189033 |
| 117 | NUAK1 | 0.39374704 |
| 118 | TRPM7 | 0.38726284 |
| 119 | PRKD2 | 0.38562677 |
| 120 | PIK3CG | 0.38433255 |
| 121 | MAP2K1 | 0.36079088 |
| 122 | CDK4 | 0.35285954 |
| 123 | MAPK11 | 0.34160139 |
| 124 | RPS6KA5 | 0.33168705 |
| 125 | PTK2 | 0.32969216 |
| 126 | DYRK1B | 0.32577591 |
| 127 | DAPK3 | 0.31701526 |
| 128 | IGF1R | 0.31563016 |
| 129 | PRKD1 | 0.30168346 |
| 130 | PDK1 | 0.30134309 |
| 131 | BMPR1B | 0.27316762 |
| 132 | IRAK2 | 0.26968352 |
| 133 | MAPK4 | 0.25885599 |
| 134 | MAP3K7 | 0.25546757 |
| 135 | MAPKAPK2 | 0.24907008 |
| 136 | CDK19 | 0.24665114 |
| 137 | MAPK12 | 0.24381343 |
| 138 | ERBB3 | 0.23650362 |
| 139 | CSNK1G2 | 0.23429465 |
| 140 | INSR | 0.21243177 |
| 141 | STK11 | 0.18733563 |
| 142 | MARK2 | 0.18027429 |
| 143 | DAPK2 | 0.14457528 |
| 144 | MAPK3 | 0.14021816 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Allograft rejection_Homo sapiens_hsa05330 | 3.88455613 |
| 2 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.58488048 |
| 3 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.57566102 |
| 4 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.57409098 |
| 5 | Lysosome_Homo sapiens_hsa04142 | 3.25238426 |
| 6 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 3.02486218 |
| 7 | Asthma_Homo sapiens_hsa05310 | 2.95932878 |
| 8 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.84952392 |
| 9 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.78874403 |
| 10 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.78371263 |
| 11 | Leishmaniasis_Homo sapiens_hsa05140 | 2.50617477 |
| 12 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.37602535 |
| 13 | Pertussis_Homo sapiens_hsa05133 | 2.25711283 |
| 14 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.08463342 |
| 15 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.04165999 |
| 16 | Phagosome_Homo sapiens_hsa04145 | 2.00793279 |
| 17 | Tuberculosis_Homo sapiens_hsa05152 | 1.97907533 |
| 18 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.97419891 |
| 19 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.83210234 |
| 20 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.82370975 |
| 21 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.77795617 |
| 22 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.77179873 |
| 23 | Other glycan degradation_Homo sapiens_hsa00511 | 1.72786497 |
| 24 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.72405961 |
| 25 | Malaria_Homo sapiens_hsa05144 | 1.70556384 |
| 26 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.67046466 |
| 27 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.59288317 |
| 28 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.57230280 |
| 29 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.54199477 |
| 30 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.46804357 |
| 31 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.44822291 |
| 32 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.44033459 |
| 33 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.36269924 |
| 34 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.34848585 |
| 35 | Apoptosis_Homo sapiens_hsa04210 | 1.29633354 |
| 36 | Salmonella infection_Homo sapiens_hsa05132 | 1.28912639 |
| 37 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.28700827 |
| 38 | Shigellosis_Homo sapiens_hsa05131 | 1.26592561 |
| 39 | Influenza A_Homo sapiens_hsa05164 | 1.21217706 |
| 40 | Measles_Homo sapiens_hsa05162 | 1.20634829 |
| 41 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.17010891 |
| 42 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.16042918 |
| 43 | Hepatitis C_Homo sapiens_hsa05160 | 1.12876305 |
| 44 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.10353403 |
| 45 | Legionellosis_Homo sapiens_hsa05134 | 1.09988300 |
| 46 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.07125793 |
| 47 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.04852488 |
| 48 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.99810071 |
| 49 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.99793509 |
| 50 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.96103542 |
| 51 | Amoebiasis_Homo sapiens_hsa05146 | 0.94902153 |
| 52 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.93526047 |
| 53 | Histidine metabolism_Homo sapiens_hsa00340 | 0.91048283 |
| 54 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.90389359 |
| 55 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.89247570 |
| 56 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.87355691 |
| 57 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.85121643 |
| 58 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.84232873 |
| 59 | Peroxisome_Homo sapiens_hsa04146 | 0.82735945 |
| 60 | Hepatitis B_Homo sapiens_hsa05161 | 0.79734048 |
| 61 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.79611139 |
| 62 | Mineral absorption_Homo sapiens_hsa04978 | 0.78279136 |
| 63 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.76529741 |
| 64 | ABC transporters_Homo sapiens_hsa02010 | 0.75581521 |
| 65 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.75545495 |
| 66 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.70131674 |
| 67 | Endocytosis_Homo sapiens_hsa04144 | 0.68593582 |
| 68 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.66912378 |
| 69 | Galactose metabolism_Homo sapiens_hsa00052 | 0.66234963 |
| 70 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.65182694 |
| 71 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.64987212 |
| 72 | Bile secretion_Homo sapiens_hsa04976 | 0.64788283 |
| 73 | HTLV-I infection_Homo sapiens_hsa05166 | 0.64101396 |
| 74 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.63879433 |
| 75 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.63031543 |
| 76 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.62956770 |
| 77 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.60723281 |
| 78 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.60417870 |
| 79 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.57179693 |
| 80 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.55650637 |
| 81 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.55649114 |
| 82 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.54527983 |
| 83 | Viral myocarditis_Homo sapiens_hsa05416 | 0.54351511 |
| 84 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.54104857 |
| 85 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.53682956 |
| 86 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.53678587 |
| 87 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.53661952 |
| 88 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.53588229 |
| 89 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.52873983 |
| 90 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.52779620 |
| 91 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.52681815 |
| 92 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.51753339 |
| 93 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.51195219 |
| 94 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.48993750 |
| 95 | Platelet activation_Homo sapiens_hsa04611 | 0.48932915 |
| 96 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.48769603 |
| 97 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.48572040 |
| 98 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.46579448 |
| 99 | Prion diseases_Homo sapiens_hsa05020 | 0.45608751 |
| 100 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.43849925 |
| 101 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.43635618 |
| 102 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.42842982 |
| 103 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.42595512 |
| 104 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.41798231 |
| 105 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.40599963 |
| 106 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.40413267 |
| 107 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.40259922 |
| 108 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.39457315 |
| 109 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.38827539 |
| 110 | Focal adhesion_Homo sapiens_hsa04510 | 0.37898028 |
| 111 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.36494080 |
| 112 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.32692574 |
| 113 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.32559295 |
| 114 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.31700596 |
| 115 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.31499427 |
| 116 | Insulin resistance_Homo sapiens_hsa04931 | 0.31392348 |
| 117 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.30864610 |
| 118 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.30863232 |
| 119 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.30515884 |
| 120 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.29832501 |
| 121 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.28461038 |
| 122 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.25014340 |
| 123 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.21205724 |
| 124 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.17881868 |
| 125 | Prostate cancer_Homo sapiens_hsa05215 | 0.17572568 |
| 126 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.16750660 |
| 127 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.16556028 |
| 128 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.16125983 |
| 129 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.13993653 |
| 130 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.13747729 |
| 131 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.13261477 |
| 132 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.11090467 |
| 133 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.10979095 |
| 134 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.10631880 |
| 135 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.09392301 |
| 136 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.07740576 |
| 137 | Glioma_Homo sapiens_hsa05214 | 0.05281572 |
| 138 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.02983502 |

